Company news
Cnbx Pharmaceuticals Inc. (OTC:CNBX) news
Cnbx Pharmaceuticals Inc. news releases on 6ix. Latest, Apr 13, 2020: Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon…
Press releases — page 2
Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer
April 13, 2020
Cannabics Pharmaceuticals Study Shows Complex Combinatorial Anti-tumor Activity of Cannabinoids
March 25, 2020
Cannabics Pharmaceuticals Offers Its High Throughput Screening (HTS) Platform to the Israeli Health Authorities for SARS-CoV-2 Research
March 18, 2020
Cannabics Pharmaceuticals Shows Specific Cultivars Identified to Have Positive Anti-Tumor Effects on Gastric Adenocarcinoma
March 11, 2020
Cannabics Pharmaceuticals Reveals Different Extraction Methods Result in Differential Necrotic Effects of Cannabis on Gastrointestinal Cancer Cells
March 2, 2020
Cannabics Pharmaceuticals Partners With NewCanna to Commence Research Based on Colombian Indigenous Cannabis Landraces
February 25, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBNA and CBCA Cause Necrosis Similarly to their Non-acidic Form
February 18, 2020
Cannabics Pharmaceuticals Collaborates With RCKMC to Develop Cannabis Strains Targeting Gastrointestinal Cancers
February 11, 2020
Cannabics Pharmaceuticals Study Shows Cannabinoids CBC and CBG Exhibit
January 27, 2020
Cannabics Pharmaceuticals Announces Cannabigerol (CBG) Shown to Have Anti-tumor Properties
January 9, 2020
Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research
December 5, 2019
Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies
October 16, 2019
Cannabics Pharmaceuticals Appoints Company's Founder to Its Board of Directors
October 7, 2019
Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA
September 12, 2019
Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments
June 28, 2019
Cannabics Pharmaceuticals Appoints Two Independent Directors
June 25, 2019
Cannabics Pharmaceuticals to Participate at the LIFT & Co. Conference in Toronto, Canada
June 4, 2019
Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California
May 29, 2019
Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies
April 17, 2019
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference
March 13, 2019
SodaStream CEO Daniel Birnbaum to Join Seedo Board
March 12, 2019
Cannabics Pharmaceuticals Closes Agreement With Wize Pharma
March 6, 2019
Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics
March 6, 2019
Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids
February 19, 2019
Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions
February 7, 2019
Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics
February 7, 2019
Cannabics Pharmaceuticals Files Four New Provisional Patent Applications for Cannabinoid-Based Drugs and Treatments for Non-Epileptic Seizures and Tremors
January 31, 2019
Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics' SR Capsules in Colombia
January 24, 2019
Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos
January 22, 2019
Cannabics Pharmaceuticals Converts $1 Million Loan Into Common Shares of Seedo
January 8, 2019
Cannabics Pharmaceuticals to be present during the J.P. Morgan Healthcare Conference In San Francisco
December 31, 2018
Cannabics Pharmaceuticals Announces New Provisional Patent Application for Personalized Cannabimetic Compositions Modeling and Production
December 26, 2018
Cannabics Pharmaceuticals Prepares ISO Application for Its Diagnostics Platform Towards Commercialization
December 11, 2018
Cannabics Pharmaceuticals Announces New Provisional Patent Application for Magnetic Targeting of Cannabinoids
November 28, 2018
CEO of Cannabics Pharmaceuticals Presenting at 11th Annual LD Micro Conference, on December 5th, 2018 in LA, California
November 27, 2018
Cannabics Pharmaceuticals Inc. CEO talks with Uptick Newswire’s Stock Day Podcast About Cancer Research in the Cannabinoid Sector
November 6, 2018
CEO of Cannabics Pharmaceutical Speaking at MJBizCon 2018 in Las Vegas
November 1, 2018
Cannabics Pharmaceuticals Granted Patent in South Africa for Its Personalized Cannabinoid Based Diagnostics
October 25, 2018
Cannabics Pharmaceuticals Announces Attendance at the CannMed 2018 Conference, Held at the UCLA Luskin Conference Center, Los Angeles, October 22-24
October 19, 2018
Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
October 16, 2018
Join Cannabics Pharmaceuticals at the 3rd CannX Medical Cannabis Conference, Held at Tel-Aviv Convention Center, Israel, October 14-16, 2018
October 9, 2018
Cannabics Pharmaceuticals Inc. Prices $7,500,000 Registered Direct Offering
September 24, 2018
Cannabics Pharmaceuticals to Present Results of Clinical Trial at International Medical Cannabis Conference
September 21, 2018
Eroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Company
September 18, 2018
Cannabics Pharmaceuticals Receives Positive Results in the Development of Cannabinoid-anticancer Drugs
September 14, 2018
Cannabics Pharmaceuticals Granted Patent in Israel for Its Core Technology for Personalized Cannabinoid Based Medicine
September 5, 2018
Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board
August 28, 2018
Cannabics Pharmaceuticals Announces That Seedo is to End Pre-Sales and Commence Delivery of Its Automated Growing Devices
August 22, 2018
Cannabics Pharmaceuticals Partners with Eroll Grow Tech to Create First Auto-Grow Device for Medical Cannabis
August 14, 2018
Cannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference
August 10, 2018